Related Experiment Video
Updated: Apr 1, 2026

05:52
Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
Published on: September 27, 2019
10.1K
A Biomimetic Core-Shell Platform for Miniaturized 3D Cell and Tissue Engineering
Pranay Agarwal1, Jung Kyu Choi1, Haishui Huang2
1Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43210 (USA). Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210 (USA).
Summary
Researchers developed a novel biomimetic core-shell platform using collagen and alginate for advanced cell and tissue culture. This system precisely controls the extracellular matrix (ECM) microenvironment to guide cell growth in 3D cultures.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Cell Biology
Background:
- The extracellular matrix (ECM) is crucial for cell behavior.
- Current 3D culture models have limitations in controlling the microenvironment.
- Biomimetic materials can better mimic native tissue conditions.
Purpose of the Study:
- To develop a novel biomimetic core-shell platform for controlled cell and tissue culture.
- To investigate the regulation of cell proliferation and development within a 3D culture system.
- To mimic key chemical and physical properties of the native ECM.
Main Methods:
- Fabrication of a core-shell structure with a collagen core and alginate hydrogel shell.
- Utilizing miniaturized three-dimensional (3D) culture techniques.
- Characterization of the platform's ability to control microenvironmental properties.
Main Results:
- Successful creation of a biomimetic core-shell platform.
- Demonstrated control over the chemical and physical properties of the core microenvironment.
- Observed regulation of cell and tissue proliferation and development.
Conclusions:
- The biomimetic core-shell platform offers a promising tool for advanced cell and tissue engineering.
- This system enables precise control over the 3D culture microenvironment.
- Potential applications in regenerative medicine and drug discovery.

